Table 2.
ETP (%) | CV-total (%) | CV-inhibition (%) | ||
---|---|---|---|---|
Volunteers (n = 20) |
Control | 100 | 22 | 0 |
UFH | 53 | 33 | 25 | |
LMWH | 40 | 35 | 21 | |
HA5 | 65 | 43 | 33 | |
Patients (n = 30) |
Control | 100 | 23 | 0 |
LMWH | 47 | 57 | 52 |
ETP (%) | CV-total (%) | CV-inhibition (%) | ||
---|---|---|---|---|
Volunteers (n = 20) |
Control | 100 | 22 | 0 |
UFH | 53 | 33 | 25 | |
LMWH | 40 | 35 | 21 | |
HA5 | 65 | 43 | 33 | |
Patients (n = 30) |
Control | 100 | 23 | 0 |
LMWH | 47 | 57 | 52 |